Publication date: December 2026 Source: Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Volume 45 Author(s): Lydia Nakiyingi, Herbert Kayonga, Stella Zawedde-Muyanja, Joseph Baluku, Joseph Musaazi, Susan Adakun, Ivan Kimuli, Harriet Mayanja-Kizza, Willy Ssengooba, William Worodria
Drivers of drug-resistant tuberculosis treatment initiation delay at three tertiary health facilities in Uganda: A mixed-methods study. // Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S2405579426000689?dgcid=rss_sd_all
Drivers of drug-resistant tuberculosis treatment initiation delay at three tertiary health facilities in Uganda: A mixed-methods study. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. https://www.sciencedirect.com/science/article/pii/S2405579426000689?dgcid=rss_sd_all
“Drivers of drug-resistant tuberculosis treatment initiation delay at three tertiary health facilities in Uganda: A mixed-methods study.” Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.
@article{article52742,
title = {Drivers of drug-resistant tuberculosis treatment initiation delay at three tertiary health facilities in Uganda: A mixed-methods study},
journal = {Journal of Clinical Tuberculosis and Other Mycobacterial Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S2405579426000689?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...